Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive leukemia that is most frequent in children and is characterized by the presence of few chromosomal rearrangements and 10 to 20 somatic mutations in protein-coding regions at diagnosis. The majority of T-ALL cases harbor activating mutations in NOTCH1 together with mutations in genes implicated in kinase signaling, transcriptional regulation, or protein translation. To obtain more insight in the level of clonal heterogeneity at diagnosis and during treatment, we used single-cell targeted DNA sequencing with the Tapestri platform. We designed a custom ALL panel and obtained accurate single-nucleotide variant and small insertion-deletion mutation calling for 305 amplicons covering 110 genes in about 4400 cells per sample and time point. A total of 108 188 cells were analyzed for 25 samples of 8 T-ALL patients. We typically observed a major clone at diagnosis (>35% of the cells) accompanied by several minor clones of which some were less than 1% of the total number of cells. Four patients had >2 NOTCH1 mutations, some of which present in minor clones, indicating a strong pressure to acquire NOTCH1 mutations in developing T-ALL cells. By analyzing longitudinal samples, we detected the presence and clonal nature of residual leukemic cells and clones with a minor presence at diagnosis that evolved to clinically relevant major clones at later disease stages. Therefore, single-cell DNA amplicon sequencing is a sensitive assay to detect clonal architecture and evolution in T-ALL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, subclones with a higher allele dropout (ADO) rate compared to the overall ADO rate of all cells were further excluded(49).”
From Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer (2023) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells
Klein, A. M., Mazutis, L., Akartuna, I., Tallapragada, N., Veres, A., Li, V., Peshkin, L., Weitz, D. A., & Kirschner, M. W. (2015) · Cell · doi:10.1016/j.cell.2015.04.044 · Cited by 3,356
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
Liu, Y., Easton, J., Shao, Y., Maciaszek, J., Wang, Z., Wilkinson, M. R., McCastlain, K., Edmonson, M., Pounds, S. B., Shi, L., et al. (2017) · Nature Genetics · doi:10.1038/ng.3909 · Cited by 918
Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours
Ma, X., Liu, Y., Liu, Y., Alexandrov, L. B., Edmonson, M. N., Gawad, C., Zhou, X., Li, Y., Rusch, M. C., Easton, J., et al. (2018) · Nature · doi:10.1038/nature25795 · Cited by 901
Developmental gene networks: a triathlon on the course to T cell identity
Yui, M. A., & Rothenberg, E. V. (2014) · Nature Reviews Immunology · doi:10.1038/nri3702 · Cited by 342
Research works printed but not linked: 28
- Belver, 2016, The genetics and mechanisms of T cell acute lymphoblastic leukaemia, Nat Rev Cancer, 16, 494, 10.1038/nrc.2016.63 · DOI · Paper page
- Girardi, 2017, The genetics and molecular biology of T-ALL, Blood, 129, 1113, 10.1182/blood-2016-10-706465 · DOI · Paper page
- Homminga, 2011, Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia, Cancer Cell, 19, 484, 10.1016/j.ccr.2011.02.008 · DOI · Paper page
- De Keersmaecker, 2013, Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia, Nat Genet, 45, 186, 10.1038/ng.2508 · DOI · Paper page
- Li, 2016, IL-7 receptor mutations and steroid resistance in pediatric T cell acute lymphoblastic leukemia: a genome sequencing study, PLoS Med, 13, e1002200, 10.1371/journal.pmed.1002200 · DOI
- Vicente, 2015, Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia, Haematologica, 100, 1301, 10.3324/haematol.2015.130179 · DOI
- Govaerts, 2019, JAK/STAT pathway mutations in T-ALL, including the STAT5B N642H mutation, are sensitive to JAK1/JAK3 inhibitors, HemaSphere, 3, e313, 10.1097/HS9.0000000000000313 · DOI
- Bornschein, 2018, Defining the molecular basis of oncogenic cooperation between TAL1 expression and Pten deletion in T-ALL using a novel pro-T-cell model system, Leukemia, 32, 941, 10.1038/leu.2017.328 · DOI
- de Bock, 2018, HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia Development, Cancer Discov, 8, 616, 10.1158/2159-8290.CD-17-0583 · DOI
- Vanden Bempt, 2018, Cooperative enhancer activation by TLX1 and STAT5 drives development of NUP214-ABL1/TLX1-positive T cell acute lymphoblastic leukemia, Cancer Cell, 34, 271, 10.1016/j.ccell.2018.07.007 · DOI
- Weng, 2004, Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia, Science, 306, 269, 10.1126/science.1102160 · DOI · Paper page
- Habets, 2019, Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibition, Sci Transl Med, 11, eaau6246, 10.1126/scitranslmed.aau6246 · DOI
- Ferrando, 2018, Can one target T-cell ALL?, Best Pract Res Clin Haematol, 31, 361, 10.1016/j.beha.2018.10.001 · DOI
- Gawad, 2014, Dissecting the clonal origins of childhood acute lymphoblastic leukemia by single-cell genomics, Proc Natl Acad Sci USA, 111, 17947, 10.1073/pnas.1420822111 · DOI · Paper page
- De Bie, 2018, Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia, Leukemia, 32, 1358, 10.1038/s41375-018-0127-8 · DOI
- Furness, 2018, The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia, Leukemia, 32, 1984, 10.1038/s41375-018-0046-8 · DOI
- Wilson, 2018, Single-cell sequencing in normal and malignant hematopoiesis, HemaSphere, 2, e34, 10.1097/HS9.0000000000000034 · DOI
- Macosko, 2015, Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets, Cell, 161, 1202, 10.1016/j.cell.2015.05.002 · DOI · Paper page
- Pellegrino, 2018, High-throughput single-cell DNA sequencing of acute myeloid leukemia tumors with droplet microfluidics, Genome Res, 28, 1345, 10.1101/gr.232272.117 · DOI · Paper page
- Kuipers, 2017, Single-cell sequencing data reveal widespread recurrence and loss of mutational hits in the life histories of tumors, Genome Res, 27, 1885, 10.1101/gr.220707.117 · DOI · Paper page
- Ou, 2019, trackViewer: a Bioconductor package for interactive and integrative visualization of multi-omics data, Nat Methods, 16, 453, 10.1038/s41592-019-0430-y · DOI · Paper page
- Zhou, 2016, Exploring genomic alteration in pediatric cancer using ProteinPaint, Nat Genet, 48, 4, 10.1038/ng.3466 · DOI · Paper page
- Springuel, 2014, Cooperating JAK1 and JAK3 mutants increase resistance to JAK inhibitors, Blood, 124, 3924, 10.1182/blood-2014-05-576652 · DOI
- Miles LA , BowmanRL, MerlinskyTR, et al Single cell mutational profiling delineates clonal trajectories in myeloid malignancies. bioRxiv. 2020; doi: 10.1101/2020.02.07.938860. · DOI
- Morita K , WangF, JahnK, et al Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics. bioRxiv. 2020; doi:10.1101/2020.02.07.925743. · doi:10.1101/2020.02.07.925743
- Mansour, 2007, Notch-1 mutations are secondary events in some patients with T-cell acute lymphoblastic leukemia, Clin Cancer Res, 13, 6964, 10.1158/1078-0432.CCR-07-1474 · DOI · Paper page
- Jenkinson, 2016, Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial, Leukemia, 30, 39, 10.1038/leu.2015.206 · DOI
- Szarzyńska-Zawadzka, 2019, PTEN abnormalities predict poor outcome in children with T-cell acute lymphoblastic leukemia treated according to ALL IC-BFM protocols, Am J Hematol, 94, E93, 10.1002/ajh.25396 · doi:10.1002/ajh.25396
Cited by
The genomic landscape of pediatric acute lymphoblastic leukemia
Brady, S. W., Roberts, K. G., Gu, Z., Shi, L., Pounds, S., Pei, D., Cheng, C., Dai, Y., Devidas, M., Qu, C., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01159-z · Cited by 391
Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
Yaeger, R., Mezzadra, R., Sinopoli, J., Bian, Y., Marasco, M., Kaplun, E., Gao, Y., Zhao, H., Paula, A. D. C., Zhu, Y., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0405 · Cited by 144
Metadata
- Authors
- Albertí-Servera, L., Demeyer, S., Govaerts, I., Swings, T., De Bie, J., Gielen, O., Brociner, M., Michaux, L., Maertens, J., Uyttebroeck, A., De Keersmaecker, K., Boeckx, N., Segers, H., & Cools, J.
- Affiliations
- Center for Human Genetics, KU Leuven, Leuven, Belgium;
- VIB Technology Watch, Technology Innovation Laboratory, VIB, Gent, Belgium;
- Department of Laboratory Medicine, UZ Leuven, Leuven, Belgium;
- Leuvens Kanker Instituut, KU Leuven–UZ Leuven, Leuven, Belgium;
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2021-02-11
- Volume
- 137
- Issue
- 6
- Pages
- 801-811
- ISSN
- 0006-4971
- 1528-0020
- Cited by
- 69
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.